MDxHealth S.A. Stock Analysis & AI Score
MDxHealth S.A. (MDXH) has an ST Score of 51.3 (C+), driven by its Valuation (A) and held back by its Momentum (D+). Analysts rate it Buy with a $2.50 price target (+329.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
MDxHealth S.A. (MDXH) has an ST Score of 51.3 (C+), driven by its Valuation (A) and held back by its Momentum (D+). Analysts rate it Buy with a $2.50 price target (+329.6% upside).
- Strongest
- ValuationA
- Weakest
- MomentumD+
All factor grades
- ValuationA
- ForecastA
- GrowthB-
- Financial StrengthC-
- ProfitabilityD+
- MomentumD+
- Piotroski4/9
Contact
MDXH stock: frequently asked questions
What is MDXH's ST Score?
MDxHealth S.A. (MDXH) has an ST Score of 51.3 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is MDXH a buy, hold, or sell?
Analysts rate MDXH a Buy, with a price target of $2.50 (+329.6% vs the current price). Our ST Score grades it C+ (51.3/100). The ST Score is a data-driven signal, not a recommendation.
What are MDXH's factor grades?
Valuation A, Profitability D+, Financial Strength C-, Momentum D+, Growth B-, Forecast A.
What is MDXH's valuation grade?
MDxHealth S.A. (MDXH) earns a valuation grade of A, measured against Medical - Diagnostics & Research peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is MDXH's growth grade?
MDxHealth S.A. (MDXH) earns a growth grade of B-, measured against Medical - Diagnostics & Research peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is MDXH's profitability grade?
MDxHealth S.A. (MDXH) earns a profitability grade of D+, measured against Medical - Diagnostics & Research peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is MDXH's financial strength grade?
MDxHealth S.A. (MDXH) earns a financial strength grade of C-, measured against Medical - Diagnostics & Research peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for MDXH?
The average analyst price target for MDxHealth S.A. (MDXH) is $2.50 from 6 analysts, which is +329.6% versus the recent price of $0.58.
What is MDXH's Piotroski score?
MDxHealth S.A. (MDXH) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.